Informações:
Sinopse
The MDS Podcast channel was created with the ultimate goal of improving education in Parkinson's disease and other movement disorders, while keeping MDS members, other neurologists, health professionals and neuroscientists updated with novel and clinically-relevant research findings. A monthly issue of the podcast will highlight the results of an article published in the Society journals, Movement Disorders or Movement Disorders Clinical Practice, including an interview with one of the authors of the article selected.
Episódios
-
Special Series: Approach to patients with acquired choreas
20/05/2024Dr. Ruth Walker and Dr. Molly Cincotta discuss causes of acquired chorea and approach to the work-up of a patient with an acquired chorea.
-
Hot Topic: Focused Ultrasound in Movement Disorders - Brain ablations as a therapeutic tool
13/05/2024In this Hot Topic episode, Dr. Michele Matarazzo interviews Dr. Raul Martinez on the recent evidence and future applications of focused ultrasound-based ablations in movement disorders, such as Parkinson's disease and essential tremors. Discover how this innovative approach is improving patient care and what it could mean for the future of medical treatment.
-
Special Series: Update on therapies for Huntington's disease
06/05/2024In the latest installment of the Chorea Special Series, Dr. Ruth Walker interviews Prof. Sarah Tabrizi about the current state of therapies for Huntington’s disease, and what is coming down the pipeline.
-
A new pathway to find structural variations in inherited neurological cases - the SCA4 example
29/04/2024In this episode Dr. Sarah Camargos interviews Dr. Zhonghbo Chen and Prof. Henry Houlden, first and senior author of a MDJ paper exploring a GGC repeat expansion in the ZFHX3 gene associated with spinocerebellar ataxia type 4. They describe a criative methodology to find a gene in a family with a Swedish ancestry. Journal CME is available until April 04, 2025 Read the article.
-
Special Series: Approach to patients with genetic choreas
22/04/2024Dr. Ruth Walker invites Prof. Emilia Gatto and Dr. Kevin Peikert onto the MDS Podcast for the second episode of the Chorea Special series. Together they discuss the general approach to patients with chorea of genetic etiology, with specific clues to diagnosis in terms of neurological and other features. They also discuss the nomenclature of neuroacanthocytosis syndromes, specific clues to the diagnosis in the clinical presentation and laboratory findings.
-
Concomitant pathologies and their clinical impact in multiple system atrophy
15/04/2024Dr. Eduardo Fernandez discusses with Dr. Hiroaki Sekiya the surprising findings of his study evaluating the presence of concomitant pathologies and how they impact the disease progression in a large cohort of patients with MSA from the Mayo Clinic brain bank. Read the article
-
Special Series: Phenomenology of Chorea
08/04/2024Guest editor Dr. Ruth Walker kicks off this special series on chorea by interviewing Prof. Joseph Jankovic on the phenomenology and his approach to the clinical examination of the patient with chorea.
-
Special Issue - Biomarker Updates: The Parkinson's disease pandemic
01/04/2024In this episode. Prof. Bas Bloem provides an overview of the topics covered in his lecture at the MDS-ES Focused Workshop: Diagnostic and Progression Biomarkers in Parkinson’s Disease and Atypical Parkinsonism, and discusses how biomarkers may help us identify patients and select adequate therapeutic strategies.
-
Special Issue - Biomarker Updates: The immune system in Parkinson’s disease
01/04/2024In this episode, Prof. Romero Ramos provides an overview of her presentation at the MDS-ES Focused Workshop: Diagnostic and Progression Biomarkers in Parkinson’s Disease and Atypical Parkinsonism, and discusses the role of the immune system in Parkinson's disease.
-
Special Issue - Biomarker Updates: Ongoing pharmacological developments in Parkinson’s disease and related disorders
01/04/2024In this episode, Prof. Olivier Rascol provides an overview of his presentation at the MDS-ES Focused Workshop: Diagnostic and Progression Biomarkers in Parkinson’s Disease and Atypical Parkinsonism, and discusses his view on ongoing efforts for the development of novel therapeutic strategies for Parkinson's disease and related synucleinopathies.
-
Special Issue - Biomarker Updates: A conversation on biomarkers and diagnostics of Parkinson's disease and related disorders
01/04/2024In this episode, Dr. David Burn shares his views with Prof. Tiago Outeiro on the topic of diagnostic and biomarkers in PD and atypical parkinsonism, and how these may impact the clinical practice. Recorded at the MDS-ES Focused Workshop: Diagnostic and Progression Biomarkers in Parkinson’s Disease and Atypical Parkinsonism, Feb. 29 - Mar. 02, 2024.
-
Special Episode: The wisdom of our mentors: clinical pearls in movement disorders
25/03/2024In this episode, Dr. Hugo Morales interviews Dr. Bas Bloem and Dr. Victor Fung, co-authors of "The Wisdom of Our Mentors: Clinical Pearls in Movement Disorders," who share clinical pearls and discuss how mentors' and mentees' interactions are at the center of mentorship in movement disorders and the MDS. Read the article
-
Hot Topic: Focused Ultrasound in Movement Disorders - Blood-Brain Barrier Opening
18/03/2024In this Hot Topic episode, Dr. Michele Matarazzo interviews Dr. Nir Lipsman on the Focused Ultrasound-mediated Blood-Brain Barrier Opening, from technical challenges to current evidence and future perspective of this promising technology that could provide a new way to deliver drugs in the brain.
-
Pallidotomy for Focal and Hemidystonia
11/03/2024Prof. Paresh Doshi discusses with Dr. Sara Schaefer the short- and long-term outcomes of unilateral radiofrequency pallidotomy in focal and hemidystonia patients in this single-blind cohort study published in Movement Disorders Clinical Practice. Read the article
-
Hot Topic: Focused Ultrasound in Movement Disorders - Neuromodulation
04/03/2024Dr. Michele Matarazzo interviews Dr. Robert Chen about the rapidly expanding applications of focused ultrasound-based neuromodulation in neurology, particularly in movement disorders, from tremor to Parkinson's disease. Tune in to uncover the future and potential of non-invasive neurotherapies that are setting new standards in research and patient care.
-
Erythrocytic α-synuclein and spreading pathology in Parkinson’s disease
26/02/2024Prof. Tiago Outeiro interviews Dr. Jing Zhang on his most recent paper in the Movement Disorder Journal on the erythrocytic alpha synuclein and the gut microbiome. Together they discuss alpha synuclein spreading pathology and the promising future of blood biomarkers for Parkinson’s disease. Journal CME is available until March 02, 2025 Read the article.
-
Mortality in Parkinson's disease: findings from a nationwide study from Finland
12/02/2024Dr. Jussi Sipilä joins Dr. Eduardo de Pablo-Fernandez to discuss the interesting findings of the article on mortality rate in Parkinson's disease using nationwide data from multiple health registries in Finland. Read the article
-
Local fields potentials can help DBS programming in Parkinson's disease in clinical practice
29/01/2024Dr. Michele Matarazzo interviews Prof. Andrea Kühn on her recently published article showing the potential of local fields potentials to help the programming of deep brain stimulation in patients with Parkinson's disease. Read the article
-
Deep brain stimulation for GBA-related Parkinson's disease: is it a reasonable option?
15/01/2024In this special issue Dr. Avenali and Prof. Valente share the results on a large cohort study investigating the results and risks of deep brain stimulation in people with Parkinson's disease carrying a GBA mutation. Read the article
-
Family history and genetic Alzheimer's risk and ties to Parkinson's disease
02/01/2024Dr. Sara Schaefer discusses with Prof. Xiang Gao and Xinming Xu on their study utilizing the UK biobank to explore the risk of Parkinson's disease as it relates to family history of Alzheimer's disease (AD) or dementia and to the polygenic risk score for AD. They further explore the common pathophysiological underpinnings for protein aggregation in the brain. Read the article